euro-gastroenterology-clinical-pharmacy-2019-tracks

25 / 29

Euro Gastroenterology 2019 & Clinical Pharmacy 2019 Archives of General Internal Medicine | ISSN: 2591-7951 | Volume 3
Page 49
Note:
March 25-26, 2019 | Amsterdam, Netherlands
&
GASTROENTEROLOGY AND HEPATOLOGY
4th International Conference on
CLINICAL PHARMACY & PHARMACY PRACTICE
9th World Congress on
Joint Event on
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
COMPREHENSIVE STUDY OF MICROBIOLOGICAL RESISTANCE AMONG
AL-SHIFA HOSPITAL SURGICAL WARD DURING GMR
Samaher J Younis
Al-Shifa Hospital, Palestine
Antimicrobial resistance has been identified as a major threat by the World Health Organization (WHO) due to
the lack of new antibiotics in the development pipeline and infections caused by multi-drug resistant patho-
gens becoming untreatable.
Methodology: Cross sectional retrospective observational study was conducted for nearly 4 months from
1/04/2018 to 23/07/2018 during AL-OADA GMR (Great March Retain). A comprehensive review of all culture iso-
lates from surgical departments of Al-Shifa Hospital. Internal, NICU and gynecological departments were exclud-
ed. Composite end point was taken as outcome with ease of collection and complexity of result interpretation.
981 cultures were reviewed from these: 824 pus cultures, 90 sputum cultures, 56 blood cultures and 11 central
line cultures.
Results: E-coli 28%, Klebsiella 21%, Staph aureus 21%, Pseudomonas 14%, Proteus 6%. Resistance of G negative
strains were: to third generation Cephalosporins reach 97%, 85% for Ciprofloxacin, 93% for Pipracillin, 100% Ce-
fazolin, 22% Amikacin, 47% Meropenem And 19% Colistin. Resistance of G positive strains were 81% Ampicillin,
14% Rifampicin, 41% Clindamycin, 15%Vancomycin, 50% Cefazolin, 46%Amoxy/Clavu,66% Cloxacillin, 50%Gen-
tamicin.
Conclusion and recommendations: High period prevalence of BDR was detected apparently with loosing colis-
tin as corner stone in resistant G strains. Clear steps should be taken to win the war against resistant strains
emerged, stewardship program should be planned and supported in Gaza Hospitals.
Samaher J Younis, Arch Gen Intern Med 2019, Volume 3 | DOI: 10.4066/2591-7951-C1-023
Samaher J Younis has completed her bachelor’s degree at the age of 23 from Al-Azhar University, Palestine. She is a
board-certified pharmacotherapy specialist from American College of Clinical Pharmacy. She is the head of clinical phar-
macy in Al-Shifa Hospital, lecturer in Palestine University, Gaza, Palestine. She has over 7 publications that have been
cited.
BIOGRAPHY